An interesting aspect observed in a study conducted in Romania in 2020 was that patients who only have NAFLD have lower AST/ALT and fibrosis scores than patients who have concurrent psoriasis [83]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.